Review
doi: 10.1128/JCM.41.9.4009-4015.2003.
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis
Affiliations
- PMID: 12958218
- PMCID: PMC193835
- DOI: 10.1128/JCM.41.9.4009-4015.2003
Item in Clipboard
Review
Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis
J Clin Microbiol.
2003 Sep.
No abstract available
Figures
Use of BCSA improves recovery of B. cepacia complex. (Left) MacConkey agar demonstrating overgrowth by a mucoid strain of P. aeruginosa; (right) BCSA showing the growth of B. cenocepacia (genomovar III) that cannot be visualized on the corresponding MacConkey agar.
Similar articles
-
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.J Clin Microbiol. 1996 Apr;34(4):886-91. doi: 10.1128/jcm.34.4.886-891.1996. J Clin Microbiol. 1996. PMID: 8815102 Free PMC article.
-
[Bacterial infections of the lungs in mucoviscidosis patients].MMW Fortschr Med. 2005 Jan 27;147(4):38-40. MMW Fortschr Med. 2005. PMID: 15745340 Review. German.
-
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.J R Soc Med. 2000;93 Suppl 38(Suppl 38):40-5. J R Soc Med. 2000. PMID: 10911818 Free PMC article. Review. No abstract available.
-
[Clinical criteria of infection with Staphylococcus aureus and Pseudomonas aeruginosa].Rev Mal Respir. 2003 Apr;20(2 Pt 2):S57-61. Rev Mal Respir. 2003. PMID: 12910135 Review. French. No abstract available.
-
Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).Br J Biomed Sci. 2018 Apr;75(2):101-103. doi: 10.1080/09674845.2017.1411018. Epub 2018 Mar 7. Br J Biomed Sci. 2018. PMID: 29513134 No abstract available.
Cited by
-
Culture enriched molecular profiling of the cystic fibrosis airway microbiome.PLoS One. 2011;6(7):e22702. doi: 10.1371/journal.pone.0022702. Epub 2011 Jul 28. PLoS One. 2011. PMID: 21829484 Free PMC article.
-
Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.Ann Am Thorac Soc. 2015 Jun;12(6):864-71. doi: 10.1513/AnnalsATS.201412-596OC. Ann Am Thorac Soc. 2015. PMID: 25745825 Free PMC article.
-
Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.J Clin Microbiol. 2006 Apr;44(4):1547-9. doi: 10.1128/JCM.44.4.1547-1549.2006. J Clin Microbiol. 2006. PMID: 16597890 Free PMC article.
-
Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.Pediatr Pulmonol. 2010 Jun;45(6):569-77. doi: 10.1002/ppul.21221. Pediatr Pulmonol. 2010. PMID: 20503282 Free PMC article.
-
Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis.J Cyst Fibros. 2021 Jul;20(4):692-698. doi: 10.1016/j.jcf.2021.05.015. Epub 2021 Jun 6. J Cyst Fibros. 2021. PMID: 34103251 Free PMC article.
References
-
- Aaron, S. D., W. Ferris, K. Ramotar, K. Vandemheen, F. Chan, and R. Saginur. 2002. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J. Clin. Microbiol. 40:4172-4179. - PMC - PubMed
-
- Aris, R. M., J. C. Routh, J. J. LiPuma, D. G. Heath, and P. H. Gilligan. 2001. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am. J. Respir. Crit. Care Med. 164:2102-2106. - PubMed
-
- Arpi, M., M. A. Victor, I. Mortensen, A. Gottschau, and B. Bruun. 1996. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods. APMIS 104:108-114. - PubMed
-
- Burns, J. L., R. L. Gibson, S. McNamara, D. Yim, J. Emerson, M. Rosenfeld, P. Hiatt, K. McCoy, R. Castile, A. L. Smith, and B. W. Ramsey. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183:444-452. - PubMed
-
- Burns, J. L., L. Saiman, S. Whittier, J. Krzewinski, Z. Liu, D. Larone, S. A. Marshall, and R. N. Jones. 2001. Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 39:257-260. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
